# Center for Comprehensive Care and Diagnosis of Inherited Blood

Grantmaking public charity, Orange, California. EIN 27-0179192.

Source: the foundation’s own IRS returns, read November 21, 2026, as shown by the Alleviate Index. https://transform.alleviate.org/index/funder/center-for-comprehensive-care-and-diagnosis-of-inherited-270179192

## Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Center for Comprehensive Care and Diagnosis of Inherited Blood accepts applications.

## What it gave

- Grants paid: $4,798,968 (Year ending September 2025)
- Grants listed: 24 (To organizations, on that return)
- Typical grant: $108,714 (Half fall between $56,925 and $163,338)

- September 2025: Grants paid $4,798,968; Grants listed 24
- September 2024: Grants paid $3,721,099; Grants listed 23

From Schedule I of its Form 990 returns for the years ending September 2024 to September 2025.

## What it funds, and where

- Focus, by share of linked grant dollars: Disease and disorders 76%, Health care 24%
- Where it gave, by number of grants: California 30, Arizona 4, Hawaii 2, Oregon 2, Washington 2, Nevada 2, Colorado 2, Utah 2, Maryland 1

## Recent grants to organizations

- [Sickle Cell Disease Foundation of California](https://transform.alleviate.org/index/org/sickle-cell-disease-foundation-of-california-956155962) (Ontario, California): $1,665,421, year ending September 2025. SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (DAVIS) (Sacramento, California): $515,135, year ending September 2025. SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF) (San Francisco, California): $439,866, year ending September 2025. SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- [Childrens Hospital & Research Center Foundation](https://transform.alleviate.org/index/org/childrens-hospital-and-research-center-foundation-941657474) (Oakland, California): $350,918, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSD) (San Diego, California): $228,544, year ending September 2025. SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL (Torrance, California): $170,895, year ending September 2025. SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCLA) (Los Angeles, California): $160,820, year ending September 2025. SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- ARROWHEAD REGIONAL MEDICAL CENTER (Colton, California): $155,377, year ending September 2025. SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- [Hemostasis and Thrombosis Center of Nevada](https://transform.alleviate.org/index/org/hemostasis-and-thrombosis-center-of-nevada-822793154) (Las Vegas, Nevada): $115,554, year ending September 2025. SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
- [Kern Medical Center Foundation](https://transform.alleviate.org/index/org/kern-medical-center-foundation-364642420) (Bakersfield, California): $113,701, year ending September 2025. SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- VALLEY CHILDREN'S HOSPITAL OF CENTRAL CALIFORNIA (Madrea, California): $110,594, year ending September 2025. SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
- LOMA LINDA UNIVERSITY HEALTH CARE (Loma Linda, California): $109,061, year ending September 2025. SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- LUCILE PACKARD CHILDREN'S HOSPITAL AT STANFORD (Palo Alto, California): $108,368, year ending September 2025. SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
- SEATTLE CHILDREN'S HOSPITAL (Seattle, Washington): $88,076, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- CHILDREN'S HOSPITAL LOS ANGELES (Los Angeles, California): $84,693, year ending September 2025. SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
- LOS ANGELES ORTHOPAEDIC HOSPITAL (Los Angeles, California): $61,111, year ending September 2025. SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
- RADY CHILDREN'S HOSPITAL - SAN DIEGO (San Diego, California): $60,640, year ending September 2025. SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE
- PHOENIX CHILDREN'S HOSPITAL (Phoenix, Arizona): $57,597, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- UNIVERSITY OF COLORADO (Aurora, Colorado): $54,910, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- IHC HEALTH SERVICES INC (Salt Lake City, Utah): $46,827, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- THE UNIVERSITY OF ARIZONA (Tucson, Arizona): $36,419, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- KAPI'OLANI MEDICAL CENTER FOR WOMEN AND CHILDREN (Honolulu, Hawaii): $30,966, year ending September 2025. SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
- OREGON HEALTH AND SCIENCE UNIVERSITY (Portland, Oregon): $28,474, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- JOHN HOPKINS UNIVERSITY (Baltimore, Maryland): $5,000, year ending September 2025. SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF) (San Francisco, California): $829,478, year ending September 2024. SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM

Method and sources: https://transform.alleviate.org/index/method#funders
